Efficacy and Safety of Anti-Programmed Cell Death Protein-1 Immunotherapy for Advanced Hepatocellular Carcinoma With Pulmonary Metastases: A Single-Center, Retrospective Study

by Mei Zhao MM, Yiruo Zhang MM, Hua Wang MD, PhD, Pingping Liu MD, Jie Da MD, Yingying Du MD
Published 2021-09-01